| Autor: |
Rabemananjara HA, Raharinosy V, Razafimahefa RM, Ravalohery JP, Rafisandratantsoa JT, Andriamandimby SF, Rajerison M, Rahelinirina S, Harimanana A, Irinantenaina J, Olive MM, Rogier C, Tordo N, Ulrich RG, Reynes JM, Petres S, Heraud JM, Telfer S, Filippone C |
| Jazyk: |
angličtina |
| Zdroj: |
Emerging infectious diseases [Emerg Infect Dis] 2020 Mar; Vol. 26 (3), pp. 587-590. |
| DOI: |
10.3201/eid2603.190320 |
| Abstrakt: |
We conducted a national human serologic study of a hantavirus detected in Madagascar rodents using a commercial kit and a new ELISA targeting the virus. Our results suggest a conservative estimate of 2.7% (46/1,680) IgG seroprevalence. A second single-district study using the new ELISA revealed a higher prevalence (7.2%; 10/139). |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
